- Home
- ABEO vs KNOP Comparison
ABEO vs KNOP Comparison
Compare ABEO & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | KNOP |
|---|---|---|
| Founded | 1974 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 302.0M |
| IPO Year | 2005 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ABEO | KNOP |
|---|---|---|
| Price | $2.28 | $8.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $18.38 | $14.50 |
| AVG Volume (30 Days) | ★ 1.7M | 88.0K |
| Earning Date | 11-09-2026 | 12-03-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $731.38 | $0.65 |
| Revenue Next Year | $129.85 | $0.75 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $2.30 | $8.06 |
| 52 Week High | $7.65 | $11.78 |
Technical Indicators
Market Signals| Indicator | ABEO | KNOP |
|---|---|---|
| Relative Strength Index (RSI) | 17.41 | 28.77 |
| Support Level | N/A | $8.06 |
| Resistance Level | $5.77 | $10.72 |
| Average True Range (ATR) | 0.30 | 0.41 |
| MACD | -0.19 | -0.07 |
| Stochastic Oscillator | 2.26 | 30.08 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About KNOP KNOT Offshore Partners LP
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.